Concepedia

Everardo D. Saad

ED

32

Publications

1.6K

Citations

17

H-Index

2000

Active since

Affiliations

International Drug Development Institute (Belgium)(Current)

Hasselt University

The University of Texas MD Anderson Cancer Center

European Organisation for Research and Treatment of Cancer

Université Libre de Bruxelles

Everardo D. Saad is an author at International Drug Development Institute (Belgium) specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2000–2025

32

Publications

32

Potential Drug Interactions and Duplicate Prescriptions Among Cancer Patients

Rachel P. Riechelmann, Ian F. Tannock, L. Wang et al. · JNCI Journal of the National Cancer Institute · 2007 · 327 citations

Potential for drug interactions in hospitalized cancer patients

Rachel P. Riechelmann, Frederico Rafael Moreira, Òren Smaletz et al. · Cancer Chemotherapy and Pharmacology · 2005 · 156 citations

, , +5

Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined

Everardo D. Saad, Artur Katz · Annals of Oncology · 2008 · 111 citations

, , +8

Pretreatment CA 19-9 Level as a Prognostic Factor in Patients with Advanced Pancreatic Cancer Treated with Gemcitabine

Everardo D. Saad, Marcel Cerqueira César Machado, Dalia Wajsbrot et al. · International Journal of Gastrointestinal Cancer · 2002 · 109 citations

Incidence and Severity of Hand–Foot Syndrome in Colorectal Cancer Patients Treated with Capecitabine: A Single-Institution Experience

Samer Abushullaih, Everardo D. Saad, Mark F. Munsell et al. · Cancer Investigation · 2002 · 102 citations

Rows per page

1–5 of 32